Blog
Can Disney+ Really Blow Netflix Away in This Critical Market?
Disney (NYSE: DIS) caused quite a flutter last week when it revealed that it's streaming service Disney+ had clocked 8 million new subscribers within days of its launch in India. The streaming
The Surprise Bet to Beat the Coronavirus Bear Market
The coronavirus pandemic has been a human tragedy, and it's also had major impacts on the financial markets. Even though stocks have recovered somewhat from the worst depths of the coronavirus bear
Why Moderna Stock Is Rocketing Higher Today
Shares of the mid-cap biopharma Moderna, Inc. (NASDAQ: MRNA) spiked by as much as 17% in pre-market action Friday morning. The biotech's shares are surging this morning in response to a $483 million
If You Invested $1,000 in The Trade Desk IPO, Here's How Much You'd Have Today
Stock in The Trade Desk (NASDAQ: TTD) first went on sale to the public back on Sept. 21, 2016. The IPO was priced at $18 per share, and the stock closed at $30.10 a share on the first day of
Sony Just Dealt GameStop a Body Blow
There isn't much of a bull case for troubled video game retailer GameStop (NYSE: GME). The company was struggling mightily before the coronavirus pandemic as video game purchases shifted from
This Is What Apple's Low-Cost iPhone Is Really All About
It's official. Apple (NASDAQ: AAPL) is finally offering its long-anticipated budget-minded iPhone. The newest iPhone SE, unveiled on Wednesday, starts at a price of $399, which pits it directly
3 Top Oil Stocks to Buy Right Now
Oil stocks are surely caught in one of the worst times ever. The coronavirus pandemic has led many countries to impose travel restrictions, lock-downs, or other measures that have significantly
Where to Invest $1,000 Right Now
With stimulus checks starting to trickle in and the markets in flux, there's a good chance that you might have a little money to invest -- and a lot of time on your hands to make sure you get it
Better Buy: Microsoft vs. Alphabet
The coronavirus crisis has added some new complexity to the question of whether Microsoft (NASDAQ: MSFT) or Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) is the better investment. Both companies boast
Beware of These 8 Coronavirus-Related Scams
As if the coronavirus pandemic itself isn't bad enough, there are lots of scammers out there taking advantage of it -- at our expense. Many websites, including government ones like the Federal Trade
Here's Why Best Buy Stock Is Going Back Up
In just under a month, shares of Best Buy (NYSE: BBY) have risen nearly 29% as of this writing. That was a fast rebound from the more than 40% decline shares experienced earlier this year as the
Is Visa Stock a Buy?
After capping off 2019 with yet another increase in transaction volume and revenue, things have gotten hairy for Visa (NYSE: V). The fintech and digital payments leader's stock fell as much as 36%
Students Don't Want Parents Taking Out Loans on Their Behalf
These days, many people find it impossible to cover the cost of a college degree without taking out student loans. But it's not just those who are actually pursuing degrees who wind up in debt
Top Tech Stock ASML Holdings Sees No Letup in Demand
One tech stock with an extremely compelling growth runway is European semiconductor-equipment maker ASML Holdings (NASDAQ: ASML). The company is the sole technology provider of extreme ultraviolet
Disney Is Losing $30 Million per Day. Is It Time to Sell the Stock?
Walt Disney (NYSE: DIS) may be losing up to $30 million per day while its theme parks remain closed, its cruise ships docked, and its movie theaters shuttered, according to The New York Times. The
Is ResMed Stock a Buy?
The COVID-19 pandemic has focused attention on a potential shortage of ventilators to keep the most severely affected patients alive when their lungs are overwhelmed by the disease. ResMed (NYSE:
Big Lots: What Happens After the Coronavirus Passes?
Deemed an essential business, Big Lots (NYSE: BIG) has kept its stores open during the coronavirus pandemic. But the company has been confronting sluggishness in sales and adjusted operating income
Trump Stimulus Checks May Be Delayed for Low-Income Americans -- Here's the Odd Reason Why
For approximately 80 million Americans, the big day likely arrived this week. Following passage of the Coronavirus Aid, Relief, and Economic Security (CARES) Act on March 27, the first batch of
Better Buy: Kinder Morgan vs. Enterprise Products Partners
In the domestic midstream energy sector, two names stand out for their size and scale: Kinder Morgan (NYSE: KMI) and Enterprise Products Partners (NYSE: EPD). The two have fallen along with the
18% of Near-Retirees Are Unaware of 1 Key Social Security Feature
Social Security provides critical benefits to millions of retired seniors, and those who are near retirement may be banking on that income source for their golden years. But a new survey by
Don't Waste Your Money on Penny Stocks, These 2 Stocks Are Better Buys
The uncertainty that has gripped stock markets around the world makes at least one thing clear: This is no time to buy penny stocks. There never was a good time, really. Most companies that trade as
Why Investors Should Keep Their Eyes on Qualcomm Stock
Although Qualcomm (NASDAQ: QCOM) stock has suffered amid antitrust issues, coronavirus may bring another challenge to light. While its products facilitate activity in a world locked down, the
Could MercadoLibre's Stock Be a Millionaire Maker?
When it comes to e-commerce, no other platform dominates like this company. In the U.S., we'd be talking about Amazon.com, but in Latin America, the e-commerce powerhouse is MercadoLibre (NASDAQ:
Is Aimmune Therapeutics a Buy?
On March 16, Aimmune Therapeutics (NASDAQ: AIMT) announced that the first patients in the U.S. had begun treatment with its recently approved immunotherapy for peanut allergies, Palforzia. On the
What a Potential Coronavirus Vaccine Win Really Means for Moderna
The coronavirus pandemic has resulted in nearly 2 million confirmed cases worldwide, leaving businesses closed and people on lockdown to avoid further spread.
Since there is no approved treatment or


